Leukocyte adhesion deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B cell) and cellular (T cell) immunodeficiency disorder.
Primarily, leukocytes cannot escape from the blood to tissues that have been attacked by microbes. Continuous surveillance of foreign antigens by leukocyte trafficking suffers disruption as well. There are three different types of LAD:
LAD has an autosomal recessive mode of inheritance.
Leukocyte adhesion deficiency type-1 (LAD-I) is a rare, inherited combined deficiency disorder of the immune system; it affects 1 in 1 million people annually and frequently presents with recurrent, indolent bacterial infections.
The literature review of the clinical findings of patients with LAD-I reveals that recurrent infections (93.3%) and poor wound healing (86%) are the most prevalent clinical findings. A defect in CD18 (the beta subunit of the integrins) was present in all patients.
Mortality for severe leukocyte adhesion deficiency-I was reported as 75% by the age of 2 years (in an initial 1988 multicenter retrospective evaluation). Patients with moderate disease (2% to 30% CD18-expressing neutrophils) survive childhood, with multiple infections affecting the skin and mucosal surfaces; documented mortality exceeds 50% by the age of 40 years.
Deficiency of the following integrins: LFA-1/Mac-1, p150 and p95 cause the immunologic and clinical abnormalities seen in leukocyte adhesion deficiency. These proteins functions as adhesion molecules. They are present on lymphocytes, granulocytes, monocytes, and large granular lymphocytes. LFA-1, Mac-1, and glycoprotein 150/95 have a common beta chain but have distinct alpha chains denominated M1 (Mac-1 molecule), L1 (LFA-1 molecule), and X1 (p150,95 molecules). A defect in the beta subunit is accountable for the decreased expression of LFA-1/Mac-1 polypeptide. Natural killer cell activity is not affected. The lesion is on chromosome 21, noted in some patients studied by molecular biology techniques.
Characteristically, biopsy of infected tissue demonstrates inflammatory infiltrates completely devoid of neutrophils. Remnants of the umbilical cord can show a loose edematous tissue with remarkably few inflammatory cells. In contrast, there is an elevated level of peripheral blood leucocytes (over 29000/microliters) due to an impaired mobilization of leukocytes to extravascular sites of inflammation.
The classic presentation of leukocyte adhesion deficiency is recurrent bacterial infections, neutrophil adhesion defects, and umbilical cord sloughing delays. The adhesion defects result in poor leukocyte chemotaxis, particularly the neutrophil, with an inability to form pus and neutrophilia.
Individuals with leukocyte adhesion deficiency commonly suffer from bacterial infections beginning in the neonatal period. Infections such as omphalitis, pneumonia, gingivitis, and peritonitis are common and usually life-threatening due to the inability to destroy the invading pathogens. Individuals with LAD do not form abscesses because granulocytes cannot migrate to the sites of infection.
Other miscellaneous manifestations may include:
Flow Cytometry Analysis (definitive test):
Sequence analysis using genetic testing.
Quantitative Serum Immunoglobulins.
IgG antibodies (post-immunization)
IgG antibodies (post-exposure)
Detection of isohemagglutinins (IgM)
Blood lymphocyte subpopulations
Lymphocyte stimulation assays
Nitroblue tetrazolium (NBT) test (before and after stimulation with endotoxin)
Complement System Evaluation
Measurement of individuals components by immunoprecipitation tests, ELISA, or Western blotting
Complement system functional studies
Other investigations of immunodeficiency disorders
Differentials for leukocyte adhesion deficiency include the following list of disorders:
The leukocyte adhesion deficiency prognosis varies depending on the severity of the disease; it is usually fatal before one year of age. Moderate LAD cases can live longer than the third decade of life with appropriate antimicrobial therapy. Those patients with successful allogeneic hematopoietic stem cell transplant can have a better quality of life.
The most common complications are infectious diseases affecting the skin, respiratory system, gastrointestinal system, oral cavity, and some internal organs. Leukocyte adhesion deficiency has a high mortality rate.
Consanguineous couples with an affected child should be counsel about the likelihood of having another affected child. The should counsel about patient care in health and disease.
An interprofessional team should treat a patient with leukocyte adhesion deficiency, comprised of a specialty trained genetics nurse, pediatrician, geneticist, clinical immunologist, and an infectious disease specialist. This problem is not treatable in a primary care facility. Parents of a child affected with LAD should receive counsel about the disease, and the integral management of the patient. Parents also require psychological support.
|||Hanna S,Etzioni A, Leukocyte adhesion deficiencies. Annals of the New York Academy of Sciences. 2012 Feb; [PubMed PMID: 22276660]|
|||Niethammer D,Dieterle U,Kleihauer E,Wildfeuer A,Haferkamp O,Hitzig WH, An inherited defect in granulocyte function: impaired chemotaxis, phagocytosis and intracellular killing of microorganisms. Helvetica paediatrica acta. 1976 Apr; [PubMed PMID: 1270326]|
|||Stepensky PY,Wolach B,Gavrieli R,Rousso S,Ben Ami T,Goldman V,Rozovsky K,Hanna S,Etzioni A,Weintraub M, Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation. Journal of pediatric hematology/oncology. 2015 May; [PubMed PMID: 25072369]|
|||Parvaneh N,Mamishi S,Rezaei A,Rezaei N,Tamizifar B,Parvaneh L,Sherkat R,Ghalehbaghi B,Kashef S,Chavoshzadeh Z,Isaeian A,Ashrafi F,Aghamohammadi A, Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. Journal of clinical immunology. 2010 Sep; [PubMed PMID: 20549317]|
|||Cox DP,Weathers DR, Leukocyte adhesion deficiency type 1: an important consideration in the clinical differential diagnosis of prepubertal periodontitis. A case report and review of the literature. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2008 Jan; [PubMed PMID: 17618138]|
|||Movahedi M,Entezari N,Pourpak Z,Mamishi S,Chavoshzadeh Z,Gharagozlou M,Mir-Saeeid-Ghazi B,Fazlollahi MR,Zandieh F,Bemanian MH,Farhoudi A,Aghamohammadi A, Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). Journal of clinical immunology. 2007 May; [PubMed PMID: 17294145]|
|||Almarza Novoa E,Kasbekar S,Thrasher AJ,Kohn DB,Sevilla J,Nguyen T,Schwartz JD,Bueren JA, Leukocyte adhesion deficiency-I: A comprehensive review of all published cases. The journal of allergy and clinical immunology. In practice. 2018 Jul - Aug; [PubMed PMID: 29371071]|
|||Tokunaga M,Miyamura K,Ohashi H,Ishiwada N,Terakura S,Ikeguchi M,Kuwatsuka Y,Inamoto Y,Oba T,Tsuchiya S,Kodera Y, Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor. International journal of hematology. 2007 Jul; [PubMed PMID: 17675274]|
|||Nezelof C, Chronic omphalitis in a 4-month-old girl. Pathology, research and practice. 1991 Mar; [PubMed PMID: 2068017]|
|||Justiz Vaillant AA,Qurie A, Immunodeficiency 2018 Jan; [PubMed PMID: 29763203]|
|||Roberts MW,Atkinson JC, Oral manifestations associated with leukocyte adhesion deficiency: a five-year case study. Pediatric dentistry. 1990 Apr-May; [PubMed PMID: 2133935]|
|||Simpson AM,Chen K,Bohnsack JF,Lamont MN,Siddiqi FA,Gociman B, Pyoderma Gangrenosum-like Wounds in Leukocyte Adhesion Deficiency: Case Report and Review of Literature. Plastic and reconstructive surgery. Global open. 2018 Aug; [PubMed PMID: 30254829]|
|||Nigar S,Khan EA,Ahmad TA, Leukocyte adhesion defect: An uncommon immunodeficiency. JPMA. The Journal of the Pakistan Medical Association. 2018 Jan; [PubMed PMID: 29371732]|
|||Thomas C,Le Deist F,Cavazzana-Calvo M,Benkerrou M,Haddad E,Blanche S,Hartmann W,Friedrich W,Fischer A, Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood. 1995 Aug 15; [PubMed PMID: 7632973]|
|||Moutsopoulos NM,Zerbe CS,Wild T,Dutzan N,Brenchley L,DiPasquale G,Uzel G,Axelrod KC,Lisco A,Notarangelo LD,Hajishengallis G,Notarangelo LD,Holland SM, Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1. The New England journal of medicine. 2017 Mar 23 [PubMed PMID: 28328326]|
|||Weening RS,Bredius RG,Vomberg PP,van der Schoot CE,Hoogerwerf M,Roos D, Recombinant human interferon-gamma treatment in severe leucocyte adhesion deficiency. European journal of pediatrics. 1992 Feb; [PubMed PMID: 1537350]|
|||Marquardt T,Lühn K,Srikrishna G,Freeze HH,Harms E,Vestweber D, Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999 Dec 15 [PubMed PMID: 10590041]|
|||Saultier P,Szepetowski S,Canault M,Falaise C,Poggi M,Suchon P,Barlogis V,Michel G,Loyau S,Jandrot-Perrus M,Bordet JC,Alessi MC,Chambost H, Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation. Haematologica. 2018 Jun [PubMed PMID: 29472353]|
|||Yamazaki-Nakashimada M,Maravillas-Montero JL,Berrón-Ruiz L,López-Ortega O,Ramírez-Alejo N,Acevedo-Ochoa E,Rivas-Larrauri F,Llamas-Guillén B,Blancas-Galicia L,Scheffler-Mendoza S,Olaya-Vargas A,Santos-Argumedo L, Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1). Immunologic research. 2015 Mar; [PubMed PMID: 25527966]|
|||Naess A,Sjursen H,Leegaard J, Leukocyte adhesion deficiency in a Norwegian boy. Scandinavian journal of infectious diseases. 1999; [PubMed PMID: 10680995]|